These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35320449)
41. Development and Validation of the PREMM Kastrinos F; Uno H; Ukaegbu C; Alvero C; McFarland A; Yurgelun MB; Kulke MH; Schrag D; Meyerhardt JA; Fuchs CS; Mayer RJ; Ng K; Steyerberg EW; Syngal S J Clin Oncol; 2017 Jul; 35(19):2165-2172. PubMed ID: 28489507 [TBL] [Abstract][Full Text] [Related]
42. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines. Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M Tumori; 2014; 100(3):315-20. PubMed ID: 25076244 [TBL] [Abstract][Full Text] [Related]
43. Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome. Marques-de-Sá I; Castro R; Pita I; Dinis-Ribeiro M; Brandão C Scand J Gastroenterol; 2020 Jun; 55(6):701-705. PubMed ID: 32448028 [No Abstract] [Full Text] [Related]
44. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report. Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333 [TBL] [Abstract][Full Text] [Related]
45. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6. Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517 [TBL] [Abstract][Full Text] [Related]
46. Constitutional Mismatch Repair Deficiency in Israel: High Proportion of Founder Mutations in MMR Genes and Consanguinity. Baris HN; Barnes-Kedar I; Toledano H; Halpern M; Hershkovitz D; Lossos A; Lerer I; Peretz T; Kariv R; Cohen S; Half EE; Magal N; Drasinover V; Wimmer K; Goldberg Y; Bercovich D; Levi Z Pediatr Blood Cancer; 2016 Mar; 63(3):418-27. PubMed ID: 26544533 [TBL] [Abstract][Full Text] [Related]
47. The identification of Lynch syndrome in Congolese colorectal cancer patients. Poaty H; Aba Gandzion C; Soubeyran I; Gassaye D; Peko JF; Nkoua Bon JB; Gombé Mbalawa C Bull Cancer; 2017 Oct; 104(10):831-839. PubMed ID: 28988047 [TBL] [Abstract][Full Text] [Related]
48. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients. Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297 [TBL] [Abstract][Full Text] [Related]
49. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
50. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
51. Low frequency of Lynch syndrome among young patients with non-familial colorectal cancer. Goel A; Nagasaka T; Spiegel J; Meyer R; Lichliter WE; Boland CR Clin Gastroenterol Hepatol; 2010 Nov; 8(11):966-71. PubMed ID: 20655395 [TBL] [Abstract][Full Text] [Related]
52. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606 [TBL] [Abstract][Full Text] [Related]
53. Detection of DNA mismatch repair proteins in fresh human blood lymphocytes--towards a novel method for hereditary non-polyposis colorectal cancer (Lynch syndrome) screening. Hassen S; Boman BM; Ali N; Parker M; Somerman C; Ali-Khan Catts ZJ; Ali AA; Fields JZ J Exp Clin Cancer Res; 2011 Oct; 30(1):100. PubMed ID: 22017758 [TBL] [Abstract][Full Text] [Related]
54. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Pande M; Lynch PM; Hopper JL; Jenkins MA; Gallinger S; Haile RW; LeMarchand L; Lindor NM; Campbell PT; Newcomb PA; Potter JD; Baron JA; Frazier ML; Amos CI Clin Cancer Res; 2010 Feb; 16(4):1331-9. PubMed ID: 20145170 [TBL] [Abstract][Full Text] [Related]
55. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas. Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743 [TBL] [Abstract][Full Text] [Related]
56. Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome. Sleiman J; Farha N; Beard J; Bena J; Morrison S; Milicia S; Heald B; Kalady MF; Church J; Liska D; Mankaney G; Burke CA Gastrointest Endosc; 2023 Sep; 98(3):412-419.e8. PubMed ID: 37031913 [TBL] [Abstract][Full Text] [Related]
57. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients. Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758 [TBL] [Abstract][Full Text] [Related]
58. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175 [TBL] [Abstract][Full Text] [Related]
59. The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations. Helderman NC; Bajwa-Ten Broeke SW; Morreau H; Suerink M; Terlouw D; van der Werf-' T Lam AS; van Wezel T; Nielsen M Crit Rev Oncol Hematol; 2021 Jul; 163():103338. PubMed ID: 34044097 [TBL] [Abstract][Full Text] [Related]